Personalizing Prostate Cancer Screening May Improve Accuracy of Detection
Taking into account genetic factors that can change PSA levels not associated with cancer, the screening accuracy can be improved.
University of California San Francisco
Give to UCSFTaking into account genetic factors that can change PSA levels not associated with cancer, the screening accuracy can be improved.
In a first, researchers have identified chronic pain pathways in individuals directly from their neural activity, showing promising paths forward for treatment.
UCSF is the first hospital in California to offer pharmacogenetic testing for smarter prescribing. Testing identifies genetic makeup and tailors medications to improve efficacy and avoid lethal drug reactions.
From birth, Samantha has had four surgeries for heart disease. Her last surgery was aided by a 3D-printed replica of her heart, providing a detailed understanding of her heart’s anatomy. The surgery’s success allowed the now 15-year-old to lead a more normal life.
What is “social prescribing” and what is UCSF doing to promote it? UCSF experts address the health ramifications of social isolation.
The WISDOM 2.0 study aims to transform breast cancer screening by using a personalized approach and will expand to women as young as 30.
Vissers’ work on RNA tags helped found the field of epitranscriptomics, the study of how chemical marks on RNA, rather than their sequence alone, dictate the function of the molecules.
Three UCSF researchers were named 2022 fellows by the American Association for the Advancement of Science (AAAS), one of the highest honors in science.
In a breakthrough, HT became the first person in the world to receive gene-corrected stem cells for Artemis-SCID. His new immune system is life-changing.
Through decades of biobanking at UCSF, researchers were able to comprehensively map intra-cellular signaling in the cells of recurrent glioblastoma, identifying novel cell-extrinsic therapeutic targets.
Promises from companies leap ahead of medical science in promoting the use of smartwatches to screen for heart rhythm disorders says UCSF’s Gregory Marcus.